6CM
TRAW icon

683 Capital Management’s Traws Pharma TRAW Stock Holding History

683 Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,493
Closed -$476K – 183
2019
Q3 		$476K Sell
1,493
-1,085
-42% -$934K 0.05% 97
2019
Q2 		$2.75M Hold
2,578
– – 0.25% 74
2019
Q1 		$3.19M Hold
2,578
– – 0.29% 67
2018
Q4 		$2.04M Hold
2,578
– – 0.12% 87
2018
Q3 		$7.1M Hold
2,578
– – 0.46% 49
2018
Q2 		$5.87M Buy
2,578
+2,104
+444% +$6.11M 0.4% 48
2018
Q1 		$2.23M Buy
474
+391
+471% +$2.79M 0.2% 76
2017
Q4 		$697K Buy
83
+16
+24% +$165K 0.06% 114
2017
Q3 		$641K Buy
67
+12
+22% +$124K 0.07% 92
2017
Q2 		$669K Buy
+55
New +$683K 0.1% 83

Other funds holding TRAW

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HWA
Hillcrest Wealth Advisors Hazlet, New Jersey $279M AUM 21.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

683 Capital Management's TRAW Position: Q4 2019 in Review

683 Capital Management sold out of Traws Pharma (TRAW) in Q4 2019, closing a stake of 1,493 shares — an estimated $476K sold.

683 Capital Management first reported a position in TRAW in Q2 2017 and held it in 10 quarters. The position peaked at $7.1M in Q3 2018. 18 funds tracked by Wall St. Rank hold TRAW as of Q4 2019.

  • 683 Capital Management reported no remaining Traws Pharma position as of Q4 2019 after selling out during the quarter.
  • 683 Capital Management sold 1,493 Traws Pharma shares in Q4 2019, an estimated $476K.
  • 683 Capital Management first reported a position in Traws Pharma in Q2 2017 and held it in 10 quarters.
  • 683 Capital Management's Traws Pharma position peaked at $7.1M in Q3 2018.
  • 18 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2019.

Based on 683 Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.